Therapeutic effect and safety of Retinalamin® medication in the treatment of myopia. Results of a clinical study.
The paper presents the results of a clinical study of the therapeutic effect and safety of Retinalamin® medication in the treatment of complicated myopia. The medication was injected peribulbarly for a period of 10 days. A significant clinical effect of the medication for supporting therapy of moderate and high myopia has been shown. Retinalamin was shown to have a positive effect on the acuity and the quality of vision of myopic patients. The medication was well tolerated by the patients and caused no general or local allergic reactions. A statistically significant positive change of the major parameters of light sensitivity of the visual field was noted. The data of electrophysiological studies revealed a positive effect of retinalamin on the functional activity of the retina, especially in its central sections. The achieved effect was stable over the whole follow-up period (up to 3 months after the course of treatment). // Russian Ophthalmological Journal, 2012; 4:19-25.